Journal of Clinical Densitometry
Volume 13, Issue 2 , Pages 141-146 , April 2010

Simplified 10-Year Absolute Fracture Risk Assessment: A Comparison of Men and Women

  • William D. Leslie

      Affiliations

    • Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
    • Department of Radiology, University of Manitoba, Winnipeg, Manitoba, Canada
    • Corresponding Author InformationAddress correspondence to: William D. Leslie, MD, MSc, Department of Medicine (C5121), St. Boniface General Hospital, 409 Tache Avenue, Winnipeg, Manitoba R2H 2A6, Canada.
    • ,
  • Lisa M. Lix

      Affiliations

    • School of Public Health, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
    • ,
  • Manitoba Bone Density Program

Received 21 December 2009 ,Revised 3 February 2010 ,Accepted 3 February 2010.

References 

  1. Tenenhouse A, Joseph L, Kreiger N, et al. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int. 2000;11:897–904
  2. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726–1733
  3. Browner WS, Pressman AR, Nevitt MC, Cummings SR. Mortality following fractures in older women. The study of osteoporotic fractures. Arch Intern Med. 1996;156:1521–1525
  4. Hannan EL, Magaziner J, Wang JJ, et al. Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes. JAMA. 2001;285:2736–2742
  5. Adachi JD, Ioannidis G, Berger C, et al. The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int. 2001;12:903–908
  6. Hallberg I, Rosenqvist AM, Kartous L, et al. Health-related quality of life after osteoporotic fractures. Osteoporos Int. 2004;15:834–841
  7. Kanis JA, Oden A, Johnell O, et al. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int. 2001;12:417–427
  8. Kanis JA, Borgstrom F, De Laet C, et al. Assessment of fracture risk. Osteoporos Int. 2005;16:581–589
  9. Siminoski K, Leslie WD, Frame H, et al. Recommendations for bone mineral density reporting in Canada: a shift to absolute fracture risk assessment. J Clin Densitom. 2007;10:120–123
  10. Leslie WD, Tsang JF, Lix L Manitoba Bone Density Program. Simplified system for absolute fracture risk assessment: clinical validation in Canadian women. J Bone Miner Res. 2009;24:353–360
  11. Leslie WD, Metge C. Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom. 2003;6:275–282
  12. Leslie WD, MacWilliam L, Lix L, et al. A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service. Osteoporos Int. 2005;16:773–782
  13. Leslie WD, Caetano PA, MacWilliam LR, Finlayson GS. Construction and validation of a population-based bone densitometry database. J Clin Densitom. 2005;8:25–30
  14. Roos NP, Shapiro E. Revisiting the Manitoba Centre for Health Policy and Evaluation and its population-based health information system. Med Care. 1999;37:JS10–JS14
  15. Hansen KE, Binkley N, Christian R, et al. Interobserver reproducibility of criteria for vertebral body exclusion. J Bone Miner Res. 2005;20:501–508
  16. Leslie WD. The importance of spectrum bias on bone density monitoring in clinical practice. Bone. 2006;39:361–368
  17. Kanis JA, Johnell O, Oden A, et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int. 2001;12:989–995
  18. Leslie WD, Tsang JF, Lix LM. Validation of ten-year fracture risk prediction: a clinical cohort study from the Manitoba Bone Density Program. Bone. 2008;43:667–671
  19. Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35:375–382
  20. Kanis JA, Johansson H, Oden A, et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res. 2004;19:893–899
  21. Kanis JA, McCloskey EV, Johansson H, et al. A reference standard for the description of osteoporosis. Bone. 2008;42:467–475
  22. Leslie WD, Tsang JF, Caetano PA, Lix LM. Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab. 2007;92:77–81
  23. Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385–397
  24. Selvin S. Epidemiologic analysis. New York, NY: Oxford University Press; 2001;
  25. Kanis JA, Johnell O, De Laet C, et al. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res. 2002;17:1237–1244
  26. Leslie WD, Lix LM, Tsang JF, Caetano PA. Single-site vs multisite bone density measurement for fracture prediction. Arch Intern Med. 2007;167:1641–1647
  27. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254–1259
  28. Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18:1033–1046
  29. Richards JB, Leslie WD, Joseph L, et al. Changes to osteoporosis prevalence according to method of risk assessment. J Bone Miner Res. 2007;22:228–234

 Disclosures—William D. Leslie: In the past 3yr, W.D.L. has received speaker fees from Merck Frosst Canada Ltd. and unrestricted research grants from Merck Frosst Canada Ltd; Sanofi-Aventis; Procter & Gamble Pharmaceuticals Canada, Inc.; Novartis; Amgen Pharmaceuticals Canada, Inc.; innovus 3M; and Genzyme Canada. He has served on advisory boards for Genzyme Canada; Novartis; and Amgen Pharmaceuticals Canada, Inc. Lisa M. Lix: In the past 3yr, L.M.L. has received unrestricted research grants from Amgen Pharmaceuticals Canada, Inc., and innovus 3M.

 Sources of support: None.

PII: S1094-6950(10)00147-2

doi: 10.1016/j.jocd.2010.02.002

Journal of Clinical Densitometry
Volume 13, Issue 2 , Pages 141-146 , April 2010

Article Tools

* Image Usage & Resolution